Skip to content
10-Q/A

Quarterly Report

Advanced BioMedical Technologies, Inc.

0001493152-20-016439

← back to feed
Filed
Aug 20, 2020 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · Aug 20, 2020 69.97M sh
Capex Q1 2020 · Jan 31, 2020 $525
Capex Q1 2020 · Jan 31, 2019 $7.97K
Operating Cash Flow Q1 2020 · Jan 31, 2020 −$51.86K
Operating Cash Flow Q1 2020 · Jan 31, 2019 −$199.77K
Cash And Equivalents Q1 2020 · Jan 31, 2020 $8.09K
Cash And Equivalents Q1 2020 · Oct 31, 2019 $5.59K
Stockholders Equity Q1 2020 · Jan 31, 2020 −$6.64M
Stockholders Equity Q1 2020 · Oct 31, 2019 −$6.48M
Stockholders Equity Q1 2020 · Jan 31, 2019 −$6.08M
Stockholders Equity Q1 2020 · Oct 31, 2018 −$5.62M
Current Liabilities Q1 2020 · Jan 31, 2020 $6.9M
Current Liabilities Q1 2020 · Oct 31, 2019 $6.7M
Current Assets Q1 2020 · Jan 31, 2020 $117.43K
Current Assets Q1 2020 · Oct 31, 2019 $119.47K
Total Assets Q1 2020 · Jan 31, 2020 $277.9K
Total Assets Q1 2020 · Oct 31, 2019 $218.5K
Sga Expense Q1 2020 · Jan 31, 2020 $54.29K
Sga Expense Q1 2020 · Jan 31, 2019 $147.93K
Rd Expense Q1 2020 · Jan 31, 2020 $56.78K
Rd Expense Q1 2020 · Jan 31, 2019 $16.98K
Net Income Q1 2020 · Jan 31, 2020 −$63.79K
Net Income Q1 2020 · Jan 31, 2019 −$252.52K
Operating Income Q1 2020 · Jan 31, 2020 −$99.65K
Operating Income Q1 2020 · Jan 31, 2019 −$169.91K
Gross Profit Q1 2020 · Jan 31, 2020 $27.37K
Cost Of Revenue Q1 2020 · Jan 31, 2020 $33.13K
Revenue Q1 2020 · Jan 31, 2020 $60.5K